Bank of Hawaii’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
DAM
F
Bank of Hawaii's NVO Position: Q1 2026 in Review
Bank of Hawaii reduced its Novo Nordisk (NVO) stake by 0.38% in Q1 2026, selling an estimated $1.52K and leaving 8,313 shares worth $306K. The position accounts for 0.02% of the portfolio, ranked #197.
Bank of Hawaii first reported a position in NVO in Q1 2016 and has held it in 18 quarters since. The position peaked at $1.96M in Q1 2018. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- Bank of Hawaii held 8,313 shares of Novo Nordisk worth $306K as of Q1 2026.
- Bank of Hawaii sold 32 Novo Nordisk shares in Q1 2026, an estimated $1.52K.
- Novo Nordisk made up 0.02% of Bank of Hawaii's portfolio in Q1 2026, its #197 holding.
- Bank of Hawaii first reported a position in Novo Nordisk in Q1 2016 and has held it in 18 quarters since.
- Bank of Hawaii's Novo Nordisk position peaked at $1.96M in Q1 2018.
- 1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on Bank of Hawaii's 13F filing for Q1 2026, filed 15 May 2026.